Informations générales (source: ClinicalTrials.gov)
Association of Lung Microbiota With Intensive Care Unit Mortality in ARDS Patients: MicrA Study (MicrA)
Observational
University of Bordeaux (Voir sur ClinicalTrials)
octobre 2019
novembre 2020
29 juin 2024
Acute respiratory distress syndrome (ARDS) is due to diffuse and severe lung
inflammation. Despite intensive research, few therapeutics have emerged and treatment is
still mostly symptomatic. As lung microbiota seems to be associated with lung
inflammation in numerous chronic respiratory diseases, this study aims to analyse the
correlation between lung microbiota and mortality.
Etablissements
Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
Medical intensive care unit, Pellegrin hospital - 33000 - Bordeaux - Nouvelle-Aquitaine - France | Didier Gruson, Prof | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
- Patient above 18 year-old admitted to intensive care unit
- ARDS according to Berlin criteria
- Needing oro-tracheal intubation for mechanical ventilation
- Within the first 48 hours of ARDS evolution
- Patient above 18 year-old admitted to intensive care unit
- ARDS according to Berlin criteria
- Needing oro-tracheal intubation for mechanical ventilation
- Within the first 48 hours of ARDS evolution
- Guardianship or curatorship
- Prisoners
- No health insurance
- No legal representative